Cronos Group

Cronos Group Rule of 40

The Rule of 40 of Cronos Group (CRON.TO) as of Oct 27, 2026 is 14.98 %. In the previous year, Rule of 40 was -30.06 % — a change of -149.82% (higher).

Rule of 40

14.98 %

YoY

-149.82%

Last updated:

Rule of 40 of Cronos Group is 2025 14.98 % . Rule of 40 of Cronos Group was 2024 -30.06 % . It decreases by -149.82% higher compared to the previous year.

The Cronos Group Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
152.29 USD
Jan 1, 2019
-391.46 USD
Jan 1, 2020
-373.52 USD
Jan 1, 2021
-414.75 USD
Jan 1, 2022
-91.73 USD
Jan 1, 2023
-97.78 USD
Jan 1, 2024
-30.06 USD
Jan 1, 2025
14.98 USD
The Cronos Group Rule of 40 history
YEARRule of 40YoY
14.98 %-149.82%
-30.06 %-69.26%
-97.78 %+6.60%
-91.73 %-77.88%
-414.75 %+11.04%
-373.52 %-4.58%
-391.46 %-357.05%
152.29 %-35.05%
234.49 %-158.22%
-402.76 %-176.73%
524.91 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cronos Group Stock analysis

What does Cronos Group do? Cronos Group Inc is a Canadian company specializing in the production and distribution of medical and recreational cannabis. It was founded in 2013 and is headquartered in Toronto, Canada. Cronos Group Inc is one of the leading cannabis producers in Canada and has also made a name for itself in the international market. History Cronos Group Inc started as a medical cannabis startup focused on the cultivation and production of high-quality cannabis products for the medical market. In 2016, the company was listed on the Toronto Stock Exchange and raised 40 million Canadian dollars through a capital increase. In 2018, it received a $1.8 billion investment from Altria Group Inc, one of the world's largest tobacco companies. This investment helped Cronos grow and establish itself in the global cannabis market. Business model Cronos Group Inc has a diversified business model focusing on the production, processing, and marketing of cannabis products. The company specializes in the cultivation and production of high-quality cannabis products suitable for both the medical and recreational markets. Cronos Group Inc also produces cannabis oils, vaporizer pens, and other smoke-free products. The various subsidiaries Cronos Group Inc consists of several subsidiary companies focusing on different aspects of the cannabis industry. Some of the key subsidiaries of Cronos Group Inc are: 1. Peace Naturals - This company specializes in the cultivation of medical cannabis and also produces cannabis oils and vaporizable products. 2. Original BC - Original BC is a leading provider of recreational cannabis, offering a wide range of cannabis products. 3. Sublime Culture - Sublime Culture specializes in the production of cannabis extracts and the development of novel cannabis products like THC-infused gummy bears. Products Cronos Group Inc offers a wide range of cannabis products suitable for both the medical and recreational markets. Some of the key products of Cronos Group Inc include: 1. Cannabis oils - The company produces a wide range of cannabis oils suitable for medical and recreational use. 2. Vaporizer pens - Cronos Group Inc also produces vaporizable products for smoke-free consumption of cannabis products. 3. Edibles - The company also offers a range of novel cannabis products like THC-infused gummy bears, contributing to the growth of the market. Conclusion Cronos Group Inc is one of the leading cannabis companies worldwide specializing in the production and distribution of medical and recreational cannabis. The company has made a name for itself with its wide range of cannabis products and has grown and established itself in the international market through the investment from Altria Group Inc. Cronos Group Inc has implemented a diversified business model, offering medical cannabis, recreational cannabis, and novel cannabis products to grow in the increasing demand and provide its customers with a wide range of offerings. Cronos Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cronos Group stock

Rule of 40 of Cronos Group is 14.98 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Cronos Group since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Cronos Group

All Key Metrics — Cronos Group